CDMOs

Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
BioSpace
Catalent
earnings
CDMOs
Flag link:
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Fierce Pharma
Catalent
Danaher
M&A
CDMOs
Flag link:
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
CP Wire
PharmaBlock
CDMOs
sustainability
Flag link:
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock
CDMOs
sustainability
Flag link:
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
CP Wire
PharmaBlock
R&D
Pennsylvania
CDMOs
Flag link:
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
PharmaBlock
R&D
Pennsylvania
CDMOs
Flag link:
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Medtech Dive
Medtech
M&A
CDMOs
Flag link:
Samsung Biologics spells out expansion plans in South Korea and US
Samsung Biologics spells out expansion plans in South Korea and US
Endpoints
Samsung BioLogics
South Korea
CDMOs
Flag link:
In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board
In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board
Fierce Pharma
Abzena
CDMOs
layoffs
antibody-drug conjugate
Flag link:
Three Ohio-based contract organizations win $149M deal for neurological candidates
Three Ohio-based contract organizations win $149M deal for neurological candidates
Endpoints
CDMOs
Battelle
AmplifyBio
Andelyn Biosciences
neurological disorders
Flag link:
Sarepta marches forward with its potential DMD gene therapy and an expanded Catalent manufacturing deal
Sarepta marches forward with its potential DMD gene therapy and an expanded Catalent manufacturing deal
Endpoints
Sarepta Therapeutics
SRP-9001
gene therapy
Duchenne Muscular Dystrophy
CDMOs
Catalent
Flag link:
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Biopharma Reporter
Delpharm
CDMOs
drug development
The Netherlands
Dr Reddy's
Flag link:
Fujifilm to build $188M manufacturing plant in North Carolina’s research triangle
Fujifilm to build $188M manufacturing plant in North Carolina’s research triangle
Endpoints
Fujifilm
CDMOs
North Carolina
drug manufacturing
RTP
Flag link:
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
CP WIre
Bend Biosciences
CoreRx
Novaquest
CDMOs
R&D
drug manufacturing
Flag link:
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
Bend Biosciences
CoreRx
Novaquest
CDMOs
R&D
drug manufacturing
Flag link:
Fujifilm continues CDMO expansion, breaking ground on $435M UK site
Fujifilm continues CDMO expansion, breaking ground on $435M UK site
Endpoints
Fujifilm
Fujifilm Diosynth Biotechnologies
CDMOs
Europe
UK
Flag link:
Samsung Biologics signs 426 bln-won land purchase deal to build 2nd campus
Samsung Biologics signs 426 bln-won land purchase deal to build 2nd campus
Yonhap News Agency
Samsung BioLogics
South Korea
CDMOs
Flag link:
Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark the largest end-to-end CDMO in Europe
Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark the largest end-to-end CDMO in Europe
Biopharma Reporter
Fujifilm
drug manufacturing
CDMOs
Flag link:
Lonza secures deal with ALSA Ventures to support its portfolio of biotechs
Lonza secures deal with ALSA Ventures to support its portfolio of biotechs
Biopharma Reporter
Lonza
ALSA Ventures
venture capital
CDMOs
Flag link:
Quiet CDMO makes noise, throwing down $500M for manufacturing campus and moving forward with China operations
Quiet CDMO makes noise, throwing down $500M for manufacturing campus and moving forward with China operations
Endpoints
VectorBuilder
CDMOs
China
chicago
drug manufacturing
Flag link:

Pages